TG Therapeutics, Inc. (TGTX) Social Stream
TG THERAPEUTICS INC (TGTX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering TGTX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 6 | $84 | $54 | $65 | $14.66 | 343.38% |
| 2021-11-10 | 6 | $84 | $54 | $64.333 | $14.66 | 338.83% |
| 2021-12-13 | 7 | $75 | $36 | $53.714 | $14.66 | 266.4% |
| 2022-01-24 | 7 | $70 | $36 | $53 | $14.66 | 261.53% |
| 2022-01-28 | 6 | $68 | $36 | $52.714 | $14.66 | 259.58% |
| 2022-02-15 | 6 | $68 | $36 | $50.285 | $14.66 | 243.01% |
| 2022-02-25 | 6 | $68 | $35 | $48.285 | $14.66 | 229.37% |
| 2022-03-02 | 7 | $68 | $35 | $48.285 | $14.66 | 229.37% |
| 2022-04-01 | 7 | $68 | $35 | $44.857 | $14.66 | 205.98% |
| 2022-04-18 | 7 | $47 | $19 | $37.857 | $14.66 | 158.23% |
| 2022-05-12 | 7 | $40.001 | $19 | $25.285 | $14.66 | 72.48% |
| 2022-06-03 | 8 | $40.001 | $5 | $22.75 | $14.66 | 55.18% |
| 2022-09-17 | 7 | $40.001 | $5 | $22 | $14.66 | 50.07% |
| 2022-11-11 | 8 | $40.001 | $5 | $22.125 | $14.66 | 50.92% |
| 2022-11-14 | 8 | $40.001 | $5 | $22.375 | $14.66 | 52.63% |
| 2022-12-29 | 9 | $40.001 | $6 | $20 | $14.66 | 36.43% |
| 2022-12-30 | 9 | $40.001 | $5 | $19.555 | $14.66 | 33.39% |
| 2023-01-03 | 9 | $40.001 | $5 | $20 | $14.66 | 36.43% |
| 2023-01-24 | 9 | $40.001 | $5 | $21.444 | $14.66 | 46.28% |
| 2023-01-26 | 9 | $26 | $6 | $19.111 | $14.66 | 30.36% |
| 2023-03-01 | 9 | $26 | $6 | $19.777 | $14.66 | 34.9% |
| 2023-03-02 | 9 | $28 | $6 | $20.777 | $14.66 | 41.73% |
The Trend in the Analyst Price Target
TGTX's average price target has moved down $47.36 over the prior 25 months.
TGTX reports an average of 203.46% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-18 | 7 | 47.000 | 19 | 37.857 | 6.92 | 447.07% |
| 2022-05-20 | 8 | 40.001 | 5 | 22.750 | 5.39 | 322.08% |
| 2022-06-13 | 7 | 40.001 | 5 | 22.000 | 4.13 | 432.69% |
| 2022-11-11 | 8 | 40.001 | 5 | 22.125 | 9.34 | 136.88% |
| 2022-11-14 | 8 | 40.001 | 5 | 19.250 | 8.71 | 121.01% |
TGTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.78 | 7 | 0 | 0 | 1 | 1 | 9 |
The Trend in the Broker Recommendations
Over the past 120 days, TGTX's average broker recommendation rating worsened by 0.4.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- TG THERAPEUTICS INC's variance in analysts' estimates is lower than -2772.99% of all US stocks.
- TG THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 2272.52% of stocks in the mid market cap category.
- In the context of stocks in the mid market cap category, TG THERAPEUTICS INC's average analyst price target is higher than 1430.58% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, TG THERAPEUTICS INC's number of analysts covering the stock is higher than 1952.03% of them.
Stocks similar to TG THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are OPK, MNKD, and AMRN.
View All Top Stocks by Price Target
Is TGTX a Buy, Hold or Sell? See the POWR Ratings now!